Nplate・ロミプレート（ロミプロスチム）の世界市場レポート 2025年：疫学、パイプライン分析、市場インサイトと予測

Nplate・ロミプレート（ロミプロスチム）市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9％で18億7,150万米ドルに成長します。予測期間の成長は、世界のヘルスケアアクセスの増加、医療経済の成長、バイオテクノロジーの技術革新の増加、効果的な治療法の増加、血液疾患の増加に起因しています。予測期間における主要動向としては、バイオシミラーの出現、治療プロトコルの進歩、技術統合、ドラッグデリバリーのアプローチ、戦略的提携、研究開発への投資などが挙げられます。

がんの罹患率の増加は、Nplate・ロミプレート（ロミプロスチム）市場の成長を促進すると予想されます。がんは、細胞の異常で制御不能な増殖を特徴とする疾患群を指します。がん患者の増加は、人口の高齢化、発がん物質への環境暴露、不健康なライフスタイルの選択（喫煙、食生活の乱れなど）、遺伝的要因、早期かつ頻繁ながん発見につながる診断技術の進歩などの要因に起因しています。Nplate・ロミプレート（ロミプロスチム）は、トロンボポエチン受容体を介して血小板産生を刺激し、血小板減少症（血小板数の減少）のリスクを低減し、血小板レベルを改善し、治療中の安全性を高め、血小板輸血の必要性を最小限に抑えることにより、がん患者、特に化学療法を受けている患者を支援します。例えば、2024年8月、オーストラリア保健福祉ラボは、人口増加とがん罹患率の増加の影響を反映し、2034年までにオーストラリアでは約20万9,000人が新たにがんと診断され、2024年の推定16万9,000人から増加すると予測しました。したがって、がん罹患率の上昇がNplate・ロミプレート（ロミプロスチム）市場を牽引することになります。

ヘルスケア支出の増加がNplate・ロミプレート（ロミプロスチム）市場の成長を促進すると予想されます。ヘルスケア支出とは、個人的なヘルスケア、予防サービス、健康結果の改善を目的とした公衆衛生活動など、ヘルスケア商品とサービスに対する総支出を指します。ヘルスケア支出の増加は、高齢化、慢性疾患、ヘルスケア技術の進歩、薬価の高騰、サービス需要の増加といった要因によってもたらされます。医療費の増加は、免疫性血小板減少性紫斑病（ITP）のような慢性疾患の治療のためのロミプロスチムのような先進的生物製剤へのアクセスを後押しします。例えば、2024年5月、国家統計局は、2022～2023年にかけて英国の総医療費が5.6％増加すると報告し、ロミプロスチム関連を含むヘルスケアサービスへの投資拡大を示唆しました。この動向は、Nplate・ロミプレート（ロミプロスチム）市場の成長を支えると考えられます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 バイオ医薬品市場における製品特性

• 分子タイプ
• 投与経路（ROA）
• 作用機序（MOA）
• 安全性と有効性

第4章 市場動向と戦略

第5章 市場-マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症、景気回復が市場に与える影響を含むマクロ経済シナリオ

第6章 世界の成長分析と戦略分析フレームワーク

• 世界のNplate・ロミプレート（ロミプロスチム）：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のNplate・ロミプレート（ロミプロスチム）市場：成長率分析
• 世界のNplate・ロミプレート（ロミプロスチム）市場の実績：規模と成長、2019～2024年
• 世界のNplate・ロミプレート（ロミプロスチム）市場の予測：規模と成長、2024～2029年、2034年
• 世界のNplate・ロミプレート（ロミプロスチム）：総潜在市場規模（TAM）

第7章 世界市場の価格分析と予測

第8章 市場セグメンテーション

• 世界のNplate・ロミプレート（ロミプロスチム）市場：患者タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 小児患者
• 成人患者
• 高齢患者
• 世界のNplate・ロミプレート（ロミプロスチム）市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 慢性免疫血小板減少症
• 化学療法誘発性血小板減少症
• その他
• 世界のNplate・ロミプレート（ロミプロスチム）市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局

第9章 臨床適応症の世界市場疫学

• 薬剤の副作用
• 臨床適応症の発症率と有病率

第10章 地域別・国別分析

• 世界のNplate・ロミプレート（ロミプロスチム）市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のNplate・ロミプレート（ロミプロスチム）市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第11章 アジア太平洋市場

第12章 中国市場

第13章 インド市場

第14章 日本市場

第15章 オーストラリア市場

第16章 韓国市場

第17章 西欧市場

第18章 英国市場

第19章 ドイツ市場

第20章 フランス市場

第21章 東欧市場

第22章 北米市場

第23章 米国市場

第24章 カナダ市場

第25章 南米市場

第26章 中東市場

第27章 アフリカ市場

第28章 競合情勢と企業プロファイル

• Nplate・ロミプレート（ロミプロスチム）市場：競合情勢
• Nplate・ロミプレート（ロミプロスチム）市場：企業プロファイル
  • Novartis AG
  • Amgen
  • Intas Pharmaceuticals

第29章 世界市場：パイプライン分析

第30章 世界の市場競合ベンチマーキングとダッシュボード

第31章 主要な合併と買収

第32章 最近の市場動向

第33章 市場の潜在力が高い国、戦略

• Nplate・ロミプレート（ロミプロスチム）市場、2029年：新たな機会を提供する国
• Nplate・ロミプレート（ロミプロスチム）市場、2029年：新たな機会を提供するセグメント
• Nplate・ロミプレート（ロミプロスチム）市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第34章 付録

Nplate and Romiplate (romiplostim) are biologic drugs classified as thrombopoietin receptor agonists, used to treat immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, increasing the risk of bleeding. Romiplostim stimulates platelet production in the bone marrow, helping maintain a safe platelet count in patients with chronic ITP.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary patient groups for nplate and romiplate (romiplostim) include pediatric, adult, and geriatric patients. This includes children and adolescents diagnosed with conditions such as chronic immune thrombocytopenia (ITP) that require Romiplate treatment. Romiplate stimulates platelet production, making it a crucial therapy for younger patients with low platelet counts. Pediatric patients may need specific dosages and close monitoring due to their developing bodies. It is used for various conditions, including chronic immune thrombocytopenia, chemotherapy-induced thrombocytopenia, and others, and is available through hospital, retail, and online pharmacies.

The nplate, romiplate (romiplostim) market research report is one of a series of new reports from The Business Research Company that provides nplate, romiplate (romiplostim) market statistics, including the nplate, romiplate (romiplostim) industry's global market size, regional shares, competitors with a nplate, romiplate (romiplostim) market share, detailed nplate, romiplate (romiplostim) market segments, market trends and opportunities, and any further data you may need to thrive in the nplate, romiplate (romiplostim) industry. This nplate, romiplate (romiplostim) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The nplate, romiplate (romiplostim) market size is expected to see strong growth in the next few years. It will grow to $1,871.5 million in 2029 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to increasing global healthcare access, growing health economics, increasing biotechnology innovations, growing effective treatments, and increasing blood disorders. Major trends in the forecast period include emerging biosimilars, advancements in treatment protocols, technology integration, drug delivery approach, strategic collaborations, and investments in research and developments.

The increasing incidence of cancer is expected to propel the growth of the nplate, romiplate (romiplostim) market. Cancer refers to a group of diseases characterized by the abnormal and uncontrolled growth of cells. The rise in cancer cases is attributed to factors such as an aging population, environmental exposure to carcinogens, unhealthy lifestyle choices (e.g., smoking, poor diet), genetic factors, and advancements in diagnostic techniques that lead to earlier and more frequent cancer detection. Nplate and Romiplate (Romiplostim) stimulate platelet production via the thrombopoietin receptor, which helps cancer patients-especially those undergoing chemotherapy-by reducing the risk of thrombocytopenia (low platelet counts), improving platelet levels, enhancing safety during treatment, and minimizing the need for platelet transfusions. For example, in August 2024, the Australian Institute of Health and Welfare projected that by 2034, Australia would see approximately 209,000 new cancer diagnoses, up from an estimated 169,000 in 2024, reflecting the impact of a growing population and increasing cancer rates. Thus, the rising cancer incidence will drive the nplate, romiplate (romiplostim) market.

Rising healthcare expenditure is expected to propel the growth of the nplate, romiplate (romiplostim) market. Healthcare expenditure refers to the total spending on healthcare goods and services, including personal health care, preventive services, and public health activities aimed at improving health outcomes. The rise in healthcare expenditure is driven by factors such as an aging population, chronic diseases, technological advancements in healthcare, high drug prices, and increased service demand. Rising healthcare expenditure boosts access to advanced biologics like Romiplostim for treating chronic conditions such as Immune Thrombocytopenic Purpura (ITP). For instance, in May 2024, the Office for National Statistics reported a 5.6% increase in total healthcare expenditure in the UK from 2022 to 2023, signaling greater investment in healthcare services, including those related to Romiplostim. This trend will support the growth of the nplate, romiplate (romiplostim) market.

A key trend in the nplate, romiplate (romiplostim) market is the development of Nplate for FDA approval to protect adults and children exposed to acute myelosuppressive doses of radiation. Nplate is now being developed for use in radiological or nuclear emergencies, with an administration kit designed to simplify its delivery. For instance, in October 2023, the Biomedical Advanced Research and Development Authority (BARDA) announced support for the development of the Nplate administration kit. This kit aims to simplify the use of Nplate during radiological or nuclear emergencies, with BARDA procuring additional doses of Nplate as part of Project BioShield. Nplate is approved to increase survival rates in both adult and pediatric patients (including newborns) exposed to myelosuppressive doses of radiation, specifically in cases of Hematopoietic Syndrome of Acute Radiation Syndrome (HSARS). This trend is part of the U.S. government's efforts to enhance preparedness for radiological and nuclear emergencies, which is expected to drive the Nplate, Romiplate (Romiplostim) market.

Major players operating in the nplate, romiplate (romiplostim) market are Novartis AG, Amgen, Intas Pharmaceuticals.

North America was the largest region in the nplate, romiplate (romiplostim) market in 2024. The regions covered in nplate, romiplate (romiplostim) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the nplate, romiplate (romiplostim) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nplate, romiplate (romiplostim) market consists of sales of the lyophilized powder for injection, nplate 500 mcg, and nplate 125 mcg. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nplate, Romiplate (romiplostim) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nplate, romiplate (romiplostim) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nplate, romiplate (romiplostim) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nplate, romiplate (romiplostim) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Patient Type: Pediatric Patients; Adult Patients; Geriatric Patients
• 2) By Application: Chronic Immune Thrombocytopenia; Chemotherapy-Induced Thrombocytopenia; Other Applications
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Companies Mentioned: Novartis AG; Amgen; Intas Pharmaceuticals
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Nplate, Romiplate (Romiplostim) Market Characteristics

3. Nplate, Romiplate (Romiplostim) Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Nplate, Romiplate (Romiplostim) Market Trends And Strategies

5. Nplate, Romiplate (Romiplostim) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Nplate, Romiplate (Romiplostim) Growth Analysis And Strategic Analysis Framework

• 6.1. Global Nplate, Romiplate (Romiplostim) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Nplate, Romiplate (Romiplostim) Market Growth Rate Analysis
• 6.4. Global Nplate, Romiplate (Romiplostim) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Nplate, Romiplate (Romiplostim) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Nplate, Romiplate (Romiplostim) Total Addressable Market (TAM)

7. Global Nplate, Romiplate (Romiplostim) Market Pricing Analysis & Forecasts

8. Nplate, Romiplate (Romiplostim) Market Segmentation

• 8.1. Global Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pediatric Patients
• Adult Patients
• Geriatric Patients
• 8.2. Global Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Immune Thrombocytopenia
• Chemotherapy-Induced Thrombocytopenia
• Other Applications
• 8.3. Global Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

9. Global Nplate, Romiplate (Romiplostim) Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Nplate, Romiplate (Romiplostim) Market Regional And Country Analysis

• 10.1. Global Nplate, Romiplate (Romiplostim) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Nplate, Romiplate (Romiplostim) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Nplate, Romiplate (Romiplostim) Market

• 11.1. Asia-Pacific Nplate, Romiplate (Romiplostim) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Nplate, Romiplate (Romiplostim) Market

• 12.1. China Nplate, Romiplate (Romiplostim) Market Overview
• 12.2. China Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Nplate, Romiplate (Romiplostim) Market

• 13.1. India Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Nplate, Romiplate (Romiplostim) Market

• 14.1. Japan Nplate, Romiplate (Romiplostim) Market Overview
• 14.2. Japan Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Nplate, Romiplate (Romiplostim) Market

• 15.1. Australia Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Nplate, Romiplate (Romiplostim) Market

• 16.1. South Korea Nplate, Romiplate (Romiplostim) Market Overview
• 16.2. South Korea Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Nplate, Romiplate (Romiplostim) Market

• 17.1. Western Europe Nplate, Romiplate (Romiplostim) Market Overview
• 17.2. Western Europe Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Nplate, Romiplate (Romiplostim) Market

• 18.1. UK Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Nplate, Romiplate (Romiplostim) Market

• 19.1. Germany Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Nplate, Romiplate (Romiplostim) Market

• 20.1. France Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nplate, Romiplate (Romiplostim) Market

• 21.1. Eastern Europe Nplate, Romiplate (Romiplostim) Market Overview
• 21.2. Eastern Europe Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Nplate, Romiplate (Romiplostim) Market

• 22.1. North America Nplate, Romiplate (Romiplostim) Market Overview
• 22.2. North America Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Nplate, Romiplate (Romiplostim) Market

• 23.1. USA Nplate, Romiplate (Romiplostim) Market Overview
• 23.2. USA Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Nplate, Romiplate (Romiplostim) Market

• 24.1. Canada Nplate, Romiplate (Romiplostim) Market Overview
• 24.2. Canada Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Nplate, Romiplate (Romiplostim) Market

• 25.1. South America Nplate, Romiplate (Romiplostim) Market Overview
• 25.2. South America Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Nplate, Romiplate (Romiplostim) Market

• 26.1. Middle East Nplate, Romiplate (Romiplostim) Market Overview
• 26.2. Middle East Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Nplate, Romiplate (Romiplostim) Market

• 27.1. Africa Nplate, Romiplate (Romiplostim) Market Overview
• 27.2. Africa Nplate, Romiplate (Romiplostim) Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Nplate, Romiplate (Romiplostim) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Nplate, Romiplate (Romiplostim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Nplate, Romiplate (Romiplostim) Market Competitive Landscape And Company Profiles

• 28.1. Nplate, Romiplate (Romiplostim) Market Competitive Landscape
• 28.2. Nplate, Romiplate (Romiplostim) Market Company Profiles
  • 28.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.2. Amgen Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.3. Intas Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

29. Global Nplate, Romiplate (Romiplostim) Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Nplate, Romiplate (Romiplostim) Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Nplate, Romiplate (Romiplostim) Market

32. Recent Developments In The Nplate, Romiplate (Romiplostim) Market

33. Nplate, Romiplate (Romiplostim) Market High Potential Countries, Segments and Strategies

• 33.1 Nplate, Romiplate (Romiplostim) Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Nplate, Romiplate (Romiplostim) Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Nplate, Romiplate (Romiplostim) Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer